Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?



Techne Buying Bionostics from $104 Million

By  +Follow June 18, 2013 1:06PM
Tickers Mentioned:

Techne Corporation (TECH) said Tuesday morning that it has agreed to spend $104 million in cash to acquire Bionostics Holdings Limited and its operating subsidiary Bionostics, Inc., in a move to strengthen its hematology division. Minneapolis, Minnesota-based Techne is a developer and manufacturer of biotechnology products and hematology calibrators and controls, operating through its two subsidiaries, R&D Systems and R&D Systems Europe.

Devans, Massachusetts-based Bionostics is focused on developing, manufacturing and distributing quality control products for in vitro diagnostic, or IVD, devices mostly used in point of care blood glucose and blood gas testing. The company was founded in 1981.

Bionostics recorded about $29.3 million in revenue for its fiscal year ended August 31, 2012 with EBIDTA of approximately $9.4 million.

Bionostics recently launched coagulation device control products and is in the process of developing controls for cholesterol and hemoglobin A1c point-of-care-testing devices. HbA1c testing in regarded as the gold standard in measuring glycemic control in diabetes patients. The company is looking to capitalize in an ongoing shift of testing being done less frequently in the laboratory setting and more often in operating rooms, bedsides, clinics, homes, etc., known as point-of-care testing.

Techne expects the acquisition to be slightly accretive in fiscal 2014 earnings.

"This business is how Techne R&D Systems was founded some 30 years ago and remains thriving today. The addition of Bionostics adds capabilities in exciting new areas like coagulation and expands our controls portfolio, giving us the critical mass we need to remain competitive and offer our customers continued value and options to serve their needs,” said Charles R. Kummeth, president and chief executive of Techne.

Subsequent to the closing of the transaction, expected in the first quarter of fiscal 2014, Bionostics and Techne’s hematology division will join forces in a new Clinical Controls Division of R&D Systems. Michael Thomas, the current CEO of Bionostics, will serve as a consultant to Techne “for a period” after the closing, according to Techne.

Shares of TECH, a relatively thinly traded stock, are ahead by 1.7 percent in Tuesday trading at $68.23 on light volume of 26,300 shares changing hands. So fare in 2013, shares are essentially flat, but have climbed from a 52-week low of $62.26 late on April 30.

For the third quarter of fiscal 2013, ended March 31, Techne reported earnings of $33.1 million, or 90 cents per share, on revenue of $80.99 million (down from sales of $83.62 million in the year prior quarter). Adjusted earnings were $32.46 million, or 88 cents per share, compared to $33.53, or 91 cents per share, in the same quarter of fiscal 2012.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for tech
Media Sentiment
31 Aug 15 20:09:55
$TECH received a new alert. Find out why at http://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt #NYSE #NASDAQ #markets 555
US Banking News
31 Aug 15 20:06:49
$TECH - BIO-TECHNE Corp Stock Rating Upgraded by Zacks #TECH http://t.co/sNFgnKGKqF
Consumer News
31 Aug 15 19:39:41
BIO-TECHNE Corp Stock Rating Upgraded by Zacks $TECH http://t.co/ba2fphH5dh #acn
Breaking News Now
31 Aug 15 17:25:03
$TECH: BIO-TECHNE Corp Upgraded at Zacks (TECH): http://t.co/7fuLlbqLWV
Instrumental Data
31 Aug 15 14:01:05
BIO-TECHNE Corp $TECH 10-K now available
31 Aug 15 13:55:02
$TECH: New SEC Filing for TECH: Form 10-K (No. 0001437749-15-016645): http://t.co/U7xmDYtsqP
New SEC Filings
31 Aug 15 13:54:24
NEW SEC Filing for $TECH filed a moment ago: http://t.co/TOvndCRusD http://t.co/xIxw2l0IuV
Stock Trade Alerts
31 Aug 15 12:31:34
SHORT Seller Alert $TECH - BIO-TECHNE CORP COMMON #ShortSeller #Stocks ~ via #AlertTrade
Stock Trade Alerts
31 Aug 15 07:59:05
5-min Candle Alert $TECH - BIO-TECHNE CORP COMMON #daytrader #stocks ~ via #AlertTrade
31 Aug 15 03:22:21
Gains Over 2500% In one Trade.. Subscribe Here! http://t.co/n4FmW1UTLN .. $TECH $ETRM $OPLK
Sleek Money
30 Aug 15 05:21:42
Analysts Give Average Rating of “Strong Buy” to BIO-TECHNE Corp $TECH http://t.co/rJWStf2iBU
Breaking News Now
30 Aug 15 05:13:04
$TECH: Analysts Give Average Rating of “Strong Buy” to BIO-TECHNE Corp …: http://t.co/9kCtz6Sixk
29 Aug 15 22:44:04
TECH Techne Corp. Shares http://t.co/JFU9VbmUXx $TECH $EWO $GILD $AMBS #TECH #investing #stocks
29 Aug 15 22:41:03
MYEC MyECheck, Inc. Stock Forum http://t.co/AnBihQNNfi $MYEC $XLV $USO $TECH #MYEC #invest #nasdaq
29 Aug 15 11:44:03
TECH -0.52% Stock Charts $TECH Bio-Techne Corp. (NASDAQ) Last Updated: 08/29/2015 13:44:08 TECH Stock Chart - http://t.co/AxPFXcXRQP
29 Aug 15 09:30:35
@TrembFredrick The WS consensus for $TECH Q1 2016 has shifted significantly downwards - http://t.co/xY9XGrG5Yt
Reporting Standards
29 Aug 15 06:26:03
$TECH TECHNE CORP /MN/ filed a new #XBRL report to the #SEC. http://t.co/5mZC2IlbyM
28 Aug 15 06:06:26
$ANFI huge bounce play as short attack put in doubt. 100%-200% upside potential $MTDR $DANG $TECH investors read http://t.co/L1jwUV6Bag
28 Aug 15 05:32:02
$TECH is rated BUY, 19.0% upside by Wall Street analysts based on average ratings/targets http://t.co/h4OB3IKRHF http://t.co/VApJ9Biphd
28 Aug 15 04:04:04
$TECH $PKE: Moving Stocks: Bio-Techne Corp. (NASDAQ:TECH), Celgene …: http://t.co/ftPiC8fuxp
28 Aug 15 01:08:02
$TECH: Bio-Techne Corp (NASDAQ:TECH) Price Target Update: http://t.co/IMKlOHBSPn
Breaking News Now
27 Aug 15 11:01:05
$TECH: Stock in Focus – Bio-Techne Corp (NASDAQ:TECH): http://t.co/6Rf4yaOOJz
US Banking News
27 Aug 15 06:35:25
Brokerages Anticipate BIO-TECHNE Corp to Post $0.85 Earnings Per Share $TECH http://t.co/lL3GEaa4ar
Ticker Report
27 Aug 15 06:27:28
Brokerages Anticipate BIO-TECHNE Corp to Post $0.85 Earnings Per Share $TECH http://t.co/uEmKxeuEWL
US Banking News
27 Aug 15 06:26:37
BIO-TECHNE Corp Receives Consensus Buy Rating from Analysts $TECH http://t.co/rqck2iLfMy
Dakota Financial
27 Aug 15 06:25:04
Brokerages Anticipate BIO-TECHNE Corp to Post $0.85 Earnings Per Share $TECH http://t.co/Uo5ddpeNAV
27 Aug 15 06:23:02
$TECH: Brokerages Anticipate BIO-TECHNE Corp to Post $0.85 Earnings …: http://t.co/ttJL5pC90y
Breaking News
26 Aug 15 23:01:04
$TECH: Bio-Techne Corp Short Interest Update: http://t.co/Va4FF5iMZ1
Mario Randholm
26 Aug 15 12:52:18
$Tech Rules the $SPX to the upside http://t.co/XJUVDxivwV http://t.co/2cmGpmB4io
25 Aug 15 15:24:17
Breaking News Now
25 Aug 15 11:48:04
$TECH: Bio-Techne Corp (NASDAQ:TECH) Analyst Rating in Focus: http://t.co/3eudsEfIK6
25 Aug 15 03:43:29
This Service Made 20,000% Gains In the Last Month! Subscribe Here http://t.co/n4FmW1UTLN .. $TECH $ETRM $OPLK
The Legacy News
24 Aug 15 22:58:48
Northland Securities Reiterates “Under Review” Rating for TechFinancials $TECH http://t.co/bgFqyGpkrk
By  +Follow June 18, 2013 1:06PM



blog comments powered by Disqus

 Today's Must Reads

Welcome to Equities.com's Small-Cap Throwdown

These Analysts Called Apple's (AAPL) Collapse, Here's What They're Saying Now

7 Dow Stocks Worth Owning and a Lot that Aren't

Sprint Turnaround Has Begun

Saving the

Small-Cap Market


Small-cap stocks offer investors many benefits, ranging from higher growth potential to overlooked value opportuni... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register